1. Australia Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Alterity Therapeutics Limited

Alterity Therapeutics Limited

PRNAF
Alterity Therapeutics LimitedUS flagOther OTC
0.40
USD
- -
- -
87.00MMarket Cap

Total Valuation

Alterity Therapeutics Limited carries a market capitalization of 87.00M, placing it among publicly traded companies globally. Its enterprise value stands at 1.12M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap87.00M
Enterprise Value1.12M

Share Statistics

Alterity Therapeutics Limited currently has 182.55M shares outstanding.

Shares Outstanding182.55M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

PE RatioN/A
PS RatioN/A
PB Ratio0.98
P/TBV Ratio0.98
P/FCF RatioN/A
P/OCF RatioN/A

Financial Position

Alterity Therapeutics Limited maintains a current ratio of 12.98, meaning it holds 13.0x the short-term assets needed to cover near-term liabilities.

Current Ratio12.98
Quick Ratio12.62
Debt / Equity0.37
Debt / EBITDAN/A
Interest CoverageN/A

Stock Price Statistics

Alterity Therapeutics Limited's stock has gained approximately 166.66667% over the past 52 weeks. The 50-day moving average sits at 0.30, while the 200-day moving average is 0.08.

Beta (5Y)N/A
52-Week Price Change166.66667%
50-Day Moving Average0.30
200-Day Moving Average0.08
Average Volume (20 Days)N/A

Balance Sheet

Alterity Therapeutics Limited holds 40.66M in cash and equivalents against 155,457.00 in total debt, resulting in a net debt position of -33.16M. Total book value stands at 42.40M, with working capital of 42.34M providing operational flexibility.

Cash & Cash Equivalents40.66M
Total Debt155,457.00
Net Debt-33.16M
Equity (Book Value)42.40M
Book Value Per Share0.23
Working Capital42.34M

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-95.31
FCF YieldN/A

Stock Splits

Alterity Therapeutics Limited's most recent stock split took place on June 3, 2026 with a 50:1 split ratio.

Last Split Date6/3/2026
Split Ratio50:1

Scores

Alterity Therapeutics Limited posts an Altman Z-Score of 1.12, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.12